Dr. Reddy's Laboratories, is an Indian multinational pharmaceutical company head-quartered in Hyderabad, India.
The company was founded by Anji Reddy with the dream of becoming a center of excellence through cutting edge research and innovation. Dr Reddy's manufactures and markets a wide range of affordable pharmaceuticals for acute therapeutic areas in India and overseas.
The company has about 190 medication facilities, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology products. In 2014, Dr. Reddy Laboratories found listed among 1200 of India's most trusted brands according to the Brand Trust Report2014.Dr. Reddy is delivering high performance in the segment it operates since its inception.
Dr. Reddy's began as a large supplier to drug and chemical manufacturers of India. But it soon expanded its scale of operation by starting export to other markets which are less-regulated to gain approval from drug licensing bodies such as the U.S. Food and Drug Administration (FDA). By 2007, Dr. Reddy's had six plants producing active pharmaceutical ingredients in India which had FDA approval and seven ISO 9001 (quality) and ISO 14001 (environmental management) certified plants making patient-ready medications, which was inspected by FDA – five of them in India and two in the UK.
Some of their best-selling brands are Allopurinol tablets, Ciprofloxacin Tablets, Clopidogrel Tablets, Famotidine Tablets, Fluoxetine Capsules etc.